Abstract:Ping Luo, 1 Ying Fan, 2 Yusha Xiong, 2 Chunlin Zhang, 1 Zhiping Yang, 1 Fenglan Sun, 1 Bing Mei 1 1 Department of Laboratory Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, People's Republic of China; 2 Gongan County Maternal and Child Health Care Hospital, Jingzhou, People's Republic of China Correspondence: Bing Mei, Department of Laboratory Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, People's Republic of China, Email Objective: To describe the metabolic characteristics of gestational diabetes mellitus (GDM) and assess their effects on perinatal outcomes. Methods: A two-center nested case‒control study was designed, including 192 pregnant women with GDM and 191 pregnant women with normal glucose tolerance (NGT). Serum glucose and insulin concentrations based upon the 75 g oral glucose tolerance test (OGTT) were measured. Several indices were calculated to describe the metabolic characteristics of the subjects. The relationship between glucose metabolism parameters and pregnancy outcomes was evaluated using stepwise linear regression and binary logistic regression. Results: Compared with the NGT group, the GDM group showed significantly higher fasting and postprandial glucose parameters but significantly lower fasting and postprandial insulin responses. Meanwhile, the GDM group had significantly lower HOMA-β, DI and ISI Matsuda but comparable HOMA-IR. The IFG subgroup showed significantly lower FINS/FPG only, while the IGT and IFSG subgroups showed deficiency in both fasting and postprandial insulin response. The IFSG subgroup had the highest glucose parameters and the lowest insulin parameters, as well as significantly lower ISI Matsuda and HOMA-β than the NGT group. FPG had a significant effect on infants' birth weight, and 1hPG and FINS/FPG had a significant effect on delivery gestational age. AUC-INS, IGI 60 and DI were related to premature delivery risk after adjusting for confounders. The IFG subgroup of GDM was 2.319 times more likely to be subject to cesarean section than the NGT group. FPG, FINS/FPG, AUC-GLU, AUC-INS/AUC-GLU and HOMA-β were related to macrosomia risk. Conclusion: Beta cell dysfunction rather than insulin resistance determines the occurrence of GDM in the central Chinese population. Women with predominant insulin secretion defects had a similar risk of adverse perinatal outcomes to women with NGT. Our study provided a basis for the selection of glucose metabolism monitoring indicators useful for the prevention of adverse perinatal outcomes. Keywords: insulin resistance, insulin sensitivity, glucose metabolism, perinatal outcomes, type 2 diabetes mellitus Pregnancy is a complicated physiological process. The endocrine system and metabolism of pregnant women undergo great changes to meet the growth and nutritional needs of the fetus, especially insulin secretion and glucose metabolism. 1 Gestational diabetes mellitus (GDM) is a group of clinical syndromes characterized by hyperglycemia caused by relative and/or absolute insufficiency of insulin due to hormonal changes, chronic low-grade inflammation, weight gain, and changes in eating habits during pregnancy. 2–7 GDM is the most common endocrine disease in women during pregnancy, affecting 14% of pregnant women worldwide 8 and leading to short- and long-term adverse outcomes for the mother and their offspring, 9 such as future development of obesity, metabolic syndrome (MetS), type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) for both the mother and the offspring. 10–14 Although insulin resistance and islet β cell dysfunction are generally believed to affect glucose homeostasis and ultimately lead to the development of GDM, 15 the relative contributions of β cell function and insulin sensitivity in the pathogenesis of GDM are ambiguous, and which of the two is the primary defect is much debated. Several studies suggested that impaired insulin sensitivity was a main factor for GDM, 16,17 whereas others indicated that decreased β cell function was a predominant defect in the development of GDM, 18 especially in lean GDM subjects. 19 These inconsistent results might be attributable to different populations. However, to our knowledge, data about the Chinese population are sorely lacking, especially in central China. Moreover, the pathogenesis of GDM seems to be different in individuals exhibiting discrepant glucose metabolism characteristics. 17,20,21 Some pregnant women showed only elevated fasting blood glucose but normal postprandial blood glucose, and some showed the opp -Abstract Truncated-

Secretion of glucagon and glucagon-like peptide-1 in different glucose tolerance status during pregnancy

Serum adipocytokines in pregnant women with different glucose metabolism status

Insulin Resistance and Lipid Profile During an Oral Glucose Tolerance Test in Women with and Without Gestational Diabetes Mellitus

Detection of insulin level and its significance in OGTT in pregnant women with gestational diabetes mellitus

Clinical characteristics and pregnancy outcomes of gestational diabetes mellitus women of abnormal blood glucose of 75g OGTT

Insulin Sensitivity, Islet Cell Function, and Incretin Axis in Pregnant Women With and Without Gestational Diabetes Mellitus

Lipid and Glucose Metabolism and Their Relationship in Patients with Gestational Impaired Glucose Metabolism

One Year Follow-up Study of Insulin Secretion and Insulin Resistance of Postpartum Women with History of Different Glucose Tolerance

Comparison of Insulin Resistance and Pancreatic Β Cell Function Between the Pregnant Women with Normal and Abnormal Glucose Metabolism

Insulin resistance and insulin secretion in normal body mass index pregnant women with abnormal glucose metabolism.

Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus

Difference Between 2 H and 3 H 75 G Glucose Tolerance Test in the Diagnosis of Gestational Diabetes Mellitus (GDM): Results from a National Survey on Prevalence of GDM

1324-P: GLP-1 Hypersecretion in Gestational Diabetes

Incretin Hypersecretion in Gestational Diabetes Mellitus

Relationship Between Blood Lipid Levels of Pregnant Women with Glucose Metabolism Disorders and Perinatal Outcomes

Pregnancy glucagon-like peptide 1 predicts insulin but not glucose concentrations

Analysis Of Oral Glucose Tolerance Test In Pregnant Women With Abnormal Glucose Metabolism

Metabolic Characteristics of Gestational Diabetes Mellitus and the Effects on Pregnancy Outcomes

Reduced GLP-1 Secretion at 30 Minutes After a 75-g Oral Glucose Load Is Observed in Gestational Diabetes Mellitus: A Prospective Cohort Study

Relationship between lipid metabolism and pregnant outcomes in women with abnormal gestational glucose metabolism

Survey on abnormal glucose metabolism in gestational women and the ill influence on outcomes of pregnancy